FMP
VolitionRx Limited
VNRX
AMEX
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
0.475 USD
-0.0125 (-2.63%)
Retained Earning Schedule
Year
2024
2023
2022
2021
Retained Earnings (Previous Year)
-202.58M
-167.26M
-136.99M
-110.17M
Net Income
-26.97M
-35.32M
-30.27M
-26.97M
Stock Repurchases
0
-31.77k
0
0
Dividend Paid
0
0
0
0
Retained Earnings
-229.54M
-202.58M
-167.26M
-136.99M
Other Distributions
-26.97M
-35.35M
-30.27M
-26.81M
All figures are in USD.
